Abstract
The human peritoneal cavity contains a small number of free cells of mesenchymal cell lineage. Intraperitoneal mesenchymal cells (PMC) play supportive roles in metastasis formation on the peritoneum. In this study, we found that PMC, when co-cultuerd with human gastric cancer cells, MKN45, enhanced the proliferation of MKN45 when cultured at low, but not high, cellular density. Also, PMC suppressed apoptotic cell death of MKN45 only under low density culture conditions. Time-lapse videoanalysis clearly demonstrated that PMC randomly migrated more vigorously than did MKN45, and strongly enhanced the migration behavior of co-cultured MKN45. In fact, the majority of MKN45 migrated together in direct physical contact with PMC, and the sum of migration lengths from original position of co-cultured MKN45 for 48 hours was approximately 10 times longer than that of MKN45 cultured alone. Our data suggest that enhanced migration can increase the chance of direct contact or positional proximity among sparcely distributed MKN45, which may bring survival advantages to tumor cells. This may be one of the important mechanisms of peritoneal metastasis, since only a small number of tumor cells are considered to be disseminated in the early step of metastasis formation on the peritoneum.
Introduction
The peritoneal cavity is a common target of metastatic gastrointestinal and ovarian cancer cells [1–3]. Although, peritoneal metastasis is likely to develop from intraperitoneal free tumor cells exfoliated from the serosal surface of primary tumors [4,5], the mechanisms leading to peritoneal metastasis have not been fully elucidated. The peritoneal cavity is the largest free space in the human body. It contains a large amount of adipose tissue and is covered by mesothelium, which has a smooth and nonadhesive surface that facilitates intracoelomic movement. In addition, the peritoneal cavity physiologically contains various free cells which may have positive roles in metastasis formation, since increasing evidence suggests that tumor metastasis is critically influenced by non-malignant cells in the tumor microenvironment [6–8].
Many studies have shown that cells of mesothelial lineage can be successfully obtained by in vitro culture of peritoneal or pleural effusion [9–11]. Recently, we have suggested that these cells originate from a small number of free cells with CD90(+)CD45(-) phenotype which vigorously grow in vitro with morphological similarity to mesothelial cells. Then, we named the cells as mesothelial-like cell (MLC) and evaluated their biological functions. Interestingly, co-transfer of the MLC enhanced metastasis formation of human gastric cancer cells on the peritoneum in nude mice via the active production of fibrous stroma [3] as well as potent inhibition of T cell-mediated immunity [12]. In 2002, Foley-Comers et al initially reported the similar cells in peritoneal cavity which had a physiological function of regeneration of mesothelium [13] and later they described the cells as mesothelial progenitor cells [14]. The MLC in our previous study appear to be same cells as theirs. Here, in this study, we renamed the cells as intraperitoneal mesnchymal cells (PMC) and further investigated their roles in the process of development of peritoneal metastasis, especially from the aspect of the effects on motility of disseminated tumor cells using time-lapse videoanalysis.
Materials and Methods
Cells and Reagents
The human gastric cancer cell line, MKN45, was obtained from Riken (Tsukuba Japan, Catalogue No. RCB1001), and maintained in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% (w/v) fetal bovine serum (FBS) (Sigma, St. Louis, MO), 100 units/ml penicillin and 100 mg/ml streptomycin (Life Technologies, Inc., Grand Island, NY). Intraperitoneal mesenchymal cells (PMC) were obtained from peritoneal lavage fluid recovered from patients who underwent abdominal surgery in the Departments of Surgical Oncology or Kanamecho Hospital as described previously [12]. Written informed consent was obtained from all patients. After centrifugation of ascites or peritoneal lavage fluid at 1500 rpm for 15 min, the pellets were resuspended in PBS + 0.02% (w/v) EDTA and overlaid on Ficoll-Hypaque solution (Pharmacia Biotech, Piscataway, NJ). After centrifugation at 3000 rpm for 10 min, the intermediate layer was taken and washed twice with PBS + 0.02% (w/v) EDTA. These cells were cultured in DMEM supplemented with 10% (w/v) FCS, 100 units/ml penicillin and 100 μg/ml streptomycin in Type I collagen-coated plates or flasks (Iwaki, Tokyo Japan). After reaching confluence, the cells were removed by treatment with 0.02% (w/v) EDTA and trypsin, and passaged. After 2~3 weeks of culture, more than 95% of cells showed a CD45(-)CD90(+) phenotype, which were used for the experiments.
FITC-conjugated annexin V was purchased from Biolegend (SanDiego, CA), PE-conjugated mAbs to CD326 (EpCAM) and 7-amino-actinomycin D (7-AAD) were from Miltenyi Biotec (Auburn, CA).
This study was carried out in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board of the University of Tokyo.
In vitro evaluation of MKN45 proliferation and apoptosis
PMC (1x104) at 2~3 passages were suspended in 1 ml DMEM containing 10% FBS and seeded in Type I collagen-coated 6-well plastic plates (Iwaki, Tokyo, Japan). After an hour, various numbers of MKN45 (1x103~1x105) suspended in 1 ml of the same medium were added and cultured for several days at 37°C in 5% CO2. As control, the same numbers of MKN45 were cultured alone without PMC. In low cellular density condition (1×103~5×103 MKN45 cells/well), the culture was continued up to 14 days with half medium change every 2~3 days. In some experiments, the same number of PMC were seeded in culture inserts and transferred onto the 6-well plates containing the same number of MKN45. In some experiments, PMC were separately cultured in inserts with 0.4-μm pores to inhibit direct contact with MKN45. At the end of culture, the entire cells were harvested using 0.02% (w/v) EDTA and trypsin, washed, and stained with FITC-conjugated annexin V, PE-conjugated mAbs to CD326, and 7-AAD. Then, the cells were resuspended in 0.5ml PBS + 0.02% (w/v) EDTA, and the density of MKN45 in each sample was evaluated using flowcytometry. In short, the entire cells in each suspension were acquired for 30 seconds, and the number of cells with the annexin V(-) CD326(+) 7AAD(-) phenotype in each acquisition were gated and counted as alive MKN45 cells, which enabled the exclusion of dead cells and contaminating CD326(-) PMC. Then, the percentage of alive MKN45 co-cultured with PMC was calculated against that of MKN45 cultured alone for the same culture periods. To determine the apoptotic index of MKN45, the percentage of annexin V(+) 7AAD(+) cells was calculated in gated CD326(+) cells.
Motility analysis
As described previously, 1×104 MKN45 were seeded with or without the same number of PMC in type I collagen-coated dishes with 3.5 cm diameter, and cell movements were monitored for 48 hours using a Biostudio system (Nikon Engineering, Kanagawa, Japan). In short, photo images of a selected field were taken every 5 min for 48 hours, and movies were constructed in a time lapsed manner using Cell Image Viewer software (Nikon Engineering, Kanagawa, Japan). On each video movie, 10~17 MKN45 cells were randomly selected in a field and the locations of each cell were chronologically plotted using image analysis software, DIPP-Motion V2D (DITECT, Tokyo, Japan). Then, the motions of each cell were monitored and the total length of migration from original position in each 5 min. was summed for 48 hours in each MKN45 using the software.
Statistical analysis
The results were analyzed by paired Student’s t test or Wilcoxon’s test where appropriate. Results are given as means and differences with P <0.05 were considered significant.
Results
Characterization of PMC
Cells recovered from the peritoneal cavity were maintained as bulk cultures in 10% FCS + DMEM media on type I collagen coated plates. In all cases, the majority of the cells were CD45(+)CD90(-) leukocytes before the culture. However, under the culture condition, the CD45(-)CD90(+) cells grew vigorously in an adherent manner and became the major component. After 2~3 weeks of culture, more than 95~99% of cells showed a CD45(-)CD90(+) phenotype, which were used for the experiments (S1 Fig). In addition to CD90, those cells were positive for CD73, CD105, CD166 which were all reported to be a marker of mesenchymal stem cell. Those cells were also positive for mesenchymal markers, vimentin and type 1 collagen. Interestingly, they were positive for cytokeratin and calreticulin which may suggest the mesothelial differentiation. In contrast, those cells were totally negative for hematopoietic markers including CD14 and CD45 (S2 Fig) As described previously [3,12], we defined the cells as “mesothelial-like cell” from their morphology. In this study, however, we renamed the cells as intraperitoneal mesenchymal cells (PMC).
PMC increased proliferation and reduced apoptosis of MKN45 co-cultured at low cellular density
First, we calculated the number of MKN45 cells cultured with or without PMC using FACS to examine whether PMC can affect the in vitro proliferation of MKN45. When the cultures were started from 5x104 or 1x105 MKN45, the growth of MKN45 did not show a significant difference by the addition of PMC, although the number of MKN45 tended to be lower at 7 days, possibly due to overgrowth (Fig 1). However, when the initial number of MKN45 was reduced to 1x104 or 5x103 cells /well, the growth of MKN45 was increased by PMC at day 7 or later. The number of MKN45 cultured with PMC for 14 days reached 230±29% and 378±47% of that of MKN45 cultured alone, respectively. This suggests that PMC enhance the growth of MKN45 when cultured at low, but not high, cellular density.
Next, we examined the ratio of MKN45 that showed apoptotic cell death at 48 hours. As shown in Fig 2A, when 1x105 MKN45 were co-cultured with PMC, the ratio of apoptotic MKN45 was not affected by PMC (3.9±1.2% vs 4.6±0.9%, n = 3) In contrast, when one tenth of the number of MKN45 (1x104) were co-cultured with PMC, the percentage of apoptotic MKN45 was increased (10.9±2.4%, n = 3), which was significantly reduced by the addition of PMC (6.6±2.2%, n = 3, p<0.05). Fig 2B shows a representative FACS profile and the ratio of annexin V(+) 7AAD(+) phenotype in CD326(+) MKN45 which were cultured at low cellular density.
Effect of PMC on MKN45 behavior is not mediated by soluble factor
We next examined the growth and apoptosis of MKN45 co-cultured with PMC, avoiding cell-cell contact using a double chamber culture system. As shown in Fig 3A, the number of MKN45 at 7 days was clearly increased by PMC co-cultured in the same well (210±23%), while it was not significantly increased by PMC cultured on inserts (123±35%). Consistently, apoptosis of MKN45 was not significantly affected by PMC cultured separately (13.5±4.2% vs 15.4±4.1%) (Fig 3B). Moreover, the addition of the culture medium of PMC did not affect the ratio of apoptosis of MKN45 (S3 Fig). This indicates that the effects of PMC on the growth of MKN45 were not mediated by soluble factors, but were mostly dependent on direct contact between the two cell types.
PMC vigorously move and support long migration of MKN45 via direct physical contact
Then, we evaluated the two-dimensional movements of MKN45 cells on plastic plates. MKN45 were cultured with or without PMC under the same low cell density in dishes with 3.5 cm diameter, and the migration patterns of MKN45 were monitored for 48 hours using time lapse video analysis. Representative movies are shown in S1 and S2 Videos. In these movies, MKN45 and PMC were easily distinguished as small bright cells and large adherent cells, respectively. As shown in S1 Video, most of the MKN45 moved around in small areas close to their initial position (within circles of less than 100 μM diameter), except that were detached and flew away, possibly due to the convection current of the culture medium. In comparison, when MKN45 were cultured with PMC, PMC exhibited markedly more vigorous migration than did MKN45 (S2 Video). More interestingly, MKN45 attached to the co-cultured PMC moved together with the physical association with PMC and migrated obviously longer distance as compared with MKN45 cultured alone. In other words, tumor cells “piggy back” on the PMCs to migrate. Fig 4 shows a comparison of the 16 migration tracks of randomly selected MKN45 in a representative experiment. In 3 different experiments, the total length of migration of MKN45 co-cultured with PMC for 48 hours was almost 10 times longer than that of MKN45 cultured alone (357.7±189.6 mm vs 38.3±42.7 mm, n = 43, p<0.001) (Fig 5). Finally, we added the medium that cultured PMC for 48 hours to MKN45 and examined the motility of MKN45. However, the migration distance of these MKN45 for 48 hours was 55.9±55.1 mm (n = 17), which was not significantly different from that of MKN45 without culture medium (Fig 5). This indicates that direct contact of MKN45 with PMC is essential to enhance the migration behavior of MKN45.
Discussion
Solid tumors are composed not only of tumor cells but also of non-malignant cells, and the complex interaction among these cells is thought to enable progression and metastasis [6,15]. In previous studies, we demonstrated that PMC assist metastasis formation in the peritoneal cavity by forming a tumor permissive microenvironment [3,12]. Here, in this study, we found an additional mechanism of PMC to promote peritoneal metastasis. In the first step, we asked whether PMC can enhance the in vitro growth of MKN45, and found that the presence of PMC significantly increased the proliferation and reduced apoptosis by PMC only when MKN45 were cultured at low density. This suggests the possibility that intercellular communication that critically affects the destiny of MKN45 occurs in culture conditions of low, but not high, cellular density.
Intercellular communication is closely related to cell motility. Thus, we then used time lapse video analysis and investigated the movement of MKN45 co-cultured with PMC at the same low culture density during the early culture period. These video movies clearly demonstrated that PMC were highly motile on plastic plates as compared with MKN45, and that PMC enabled long migration of co-cultured MKN45. In fact, most of the MKN45 attached to PMC were actually “carried” by the moving PMC, whereas MKN45 that did not meet PMC showed the same pattern of migration as those cultured alone. These “lonely” MKN45 might finally undergo apoptotic cell death. From these findings, it is speculated that the enhanced migration of MKN45 causes an increased chance of physical interaction of sparsely distributed MKN45 cells, which can produce juxtacrine signaling to inhibit apoptosis and bring an advantage of cell growth, as described elsewhere [16]. Indeed, movies of the co-culture condition suggested that some of the MKN45 that moved a long distance met together with other MKN45 and formed a small cluster within 48 hours. In contrast, when MKN45 were cultured at high density, they easily made the intercellular contact even without PMC (data not shown), which may be the reason why the growth of MKN45 was not significantly affected by the presence of PMC.
Previous studies have indicated that cancer associated fibroblasts (CAF) stimulates cancer cell motility or invasion by producing soluble factors such as Hepatocyte growth factor (HGF) [17], Transforming growth factor (TGF)-β [18,19], CXCL12 [20]. In our experiments, however, the enhanced migrations as well as growth of MKN45 were considered to be totally mediated by direct contact between PMC and MKN45, because addition of the culture medium of PMC did not affect the behavior of MKN45. This is consistent with the results of recent studies which have suggested that direct interaction with fibroblasts is important to enhance tumor cell invasion [21,22] Although dependent on the experimental conditions or characteristics of tumor cells, our data suggest that physical contact with mesenchymal cells critically regulates the migration and invasive behavior of tumor cells.
Peritoneal recurrence often develops even after curative resection of abdominal malignancies [23–25]. In those cases, metatasatic foci are considered to develop from undetectable tumor cells disseminated in the peritoneal cavity. Our in vitro study provides the clear evidence that PMC support the colony formation and proliferation of sparsely distributed tumor cells. This observation seems to be clinically important in the mechanism of metastasis formation in peritoneum, because only a small number of tumor cells are supposed to be disseminated in the early step of peritoneal metastasis. Pharmacological inhibition of PMC during postoperative adjuvant chemotherapy may be another effective strategy to inhibit peritoneal recurrence of abdominal malignancy.
Supporting Information
Acknowledgments
This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan and a Grant from the Ministry of Health and Welfare of Japan and AMED:15Ack0106255h001. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Ethical approval: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Data Availability
All relevant data are within the paper and its Supporting Information files.
Funding Statement
This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan; a Grant from the Ministry of Health and Welfare of Japan; and AMED: 15Ack0106155h001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1.Yang XJ, Li Y, Yonemura Y (2010) Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat gastric cancer with ascites and/or peritoneal carcinomatosis: Results from a Chinese center. J Surg Oncol 101: 457–464. 10.1002/jso.21519 [DOI] [PubMed] [Google Scholar]
- 2.Colombo N, Van Gorp T, Parma G, Amant F, Gatta G, Sessa C, et al. (2006) Ovarian cancer. Crit Rev Oncol Hematol 60: 159–179. [DOI] [PubMed] [Google Scholar]
- 3.Kitayama J, Emoto S, Yamaguchi H, Ishigami H, Watanabe T (2014) CD90+ mesothelial-like cells in peritoneal fluid promote peritoneal metastasis by forming a tumor permissive microenvironment. PLoS ONE [Electronic Resource] 9: e86516. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Koga S, Kaibara N, Iitsuka Y, Kudo H, Kimura A, Hiraoka H. (1984) Prognostic significance of intraperitoneal free cancer cells in gastric cancer patients. J Cancer Res Clin Oncol 108: 236–238. [DOI] [PubMed] [Google Scholar]
- 5.Sodek KL, Murphy KJ, Brown TJ, Ringuette MJ (2012) Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis. Cancer Metastasis Rev 31: 397–414. 10.1007/s10555-012-9351-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Mueller MM, Fusenig NE (2004) Friends or foes—bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4: 839–849. [DOI] [PubMed] [Google Scholar]
- 7.Calvo F, Sahai E (2011) Cell communication networks in cancer invasion. Current opinion in cell biology 23: 621–629. 10.1016/j.ceb.2011.04.010 [DOI] [PubMed] [Google Scholar]
- 8.Joyce JA, Pollard JW (2009) Microenvironmental regulation of metastasis. Nature reviews Cancer 9: 239–252. 10.1038/nrc2618 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Singh G, Dekker A, Ladoulis CT (1978) Tissue culture of cells in serous effusions. Evaluation as an adjunct to cytology. Acta Cytol 22: 487–489. [PubMed] [Google Scholar]
- 10.Betjes MG, Bos HJ, Krediet RT, Arisz L (1991) The mesothelial cells in CAPD effluent and their relation to peritonitis incidence. Perit Dial Int 11: 22–26. [PubMed] [Google Scholar]
- 11.Yanez-Mo M, Lara-Pezzi E, Selgas R, Ramirez-Huesca M, Dominguez-Jimenez C, Aguilera A. et al. (2003) Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 348: 403–413. [DOI] [PubMed] [Google Scholar]
- 12.Kitayama J, Emoto S, Yamaguchi H, Ishigami H, Yamashita H, Seto Y, et al. (2014) CD90(+)CD45(-) intraperitoneal mesothelial-like cells inhibit T cell activation by production of arginase I. Cellular Immunology 288: 8–14. 10.1016/j.cellimm.2014.01.008 [DOI] [PubMed] [Google Scholar]
- 13.Foley-Comer AJ, Herrick SE, Al-Mishlab T, Prele CM, Laurent GJ, Mutsauers SE. (2002) Evidence for incorporation of free-floating mesothelial cells as a mechanism of serosal healing. J Cell Sci 115: 1383–1389. [DOI] [PubMed] [Google Scholar]
- 14.Herrick SE, Mutsaers SE (2004) Mesothelial progenitor cells and their potential in tissue engineering. Int J Biochem Cell Biol 36: 621–642. [DOI] [PubMed] [Google Scholar]
- 15.Polyak K, Haviv I, Campbell IG (2009) Co-evolution of tumor cells and their microenvironment. Trends in genetics: TIG 25: 30–38. 10.1016/j.tig.2008.10.012 [DOI] [PubMed] [Google Scholar]
- 16.Llames S, Garcia-Perez E, Meana A, Larcher F, del Rio M (2015) Feeder Layer Cell Actions and Applications. Tissue Eng Part B Rev 21: 345–353. 10.1089/ten.TEB.2014.0547 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Tyan SW, Kuo WH, Huang CK, Pan CC, Shew JY, Chang KJ, et al. (2011) Breast cancer cells induce cancer-associated fibroblasts to secrete hepatocyte growth factor to enhance breast tumorigenesis. PLoS One 6: e15313 10.1371/journal.pone.0015313 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S, et al. (2004) TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science (New York, N Y) 303: 848–851. [DOI] [PubMed] [Google Scholar]
- 19.Fuyuhiro Y, Yashiro M, Noda S, Matsuoka J, Hasegawa T, Kato Y, et al. (2012) Cancer-associated orthotopic myofibroblasts stimulates the motility of gastric carcinoma cells. Cancer science 103: 797–805. 10.1111/j.1349-7006.2012.02209.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, et al. (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121: 335–348. [DOI] [PubMed] [Google Scholar]
- 21.Semba S, Kodama Y, Ohnuma K, Mizuuchi E, Masuda R, Yashiro M, et al. (2009) Direct cancer-stromal interaction increases fibroblast proliferation and enhances invasive properties of scirrhous-type gastric carcinoma cells. British journal of cancer 101: 1365–1373. 10.1038/sj.bjc.6605309 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Yamaguchi H, Yoshida N, Takanashi M, Ito Y, Fukami K, Yanagihara K, et al. (2014) Stromal fibroblasts mediate extracellular matrix remodeling and invasion of scirrhous gastric carcinoma cells. PloS one 9: e85485 10.1371/journal.pone.0085485 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, et al. (2007) Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357: 1810–1820. [DOI] [PubMed] [Google Scholar]
- 24.Hodeib M, Eskander RN, Bristow RE (2014) New paradigms in the surgical and adjuvant treatment of ovarian cancer. Minerva ginecologica 66: 179–192. [PubMed] [Google Scholar]
- 25.Sugarbaker PH (2014) Update on the prevention of local recurrence and peritoneal metastases in patients with colorectal cancer. World journal of gastroenterology 20: 9286–9291. 10.3748/wjg.v20.i28.9286 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All relevant data are within the paper and its Supporting Information files.